By Admin at 28 Oct 2015
A new blood test may offer a significantly better option to breast cancer survivors, as it can identify patients at risk of a relapse months before tumors are visible on hospital scans.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
